4-Amino-n-[2-(diethylamino)ethyl]benzamide

CAS: 51-06-9

Ref. 3D-FA168193

Produktinformation

• Name: 4-Amino-n-[2-(diethylamino)ethyl]benzamide
• Synonyme: 4-Amino-N-(diethylaminoethyl)benzamide, 4-Amino-N-[2-(diethylamino)ethyl]benzamide, 4-amino-N-(2-diethylaminoethyl)benzamide, Benzamide, 4-amino-N-[2-(diethylamino)ethyl]-, Benzamide, p-amino-N-[2-(diethylamino)ethyl]-, N-(2-(Diethylamino)ethyl)-4-aminobenzamide, Novocainamid, Novocainamide, Novocaine amide, Novocamid, Nsc 27461, Procainamid, Procainamida, Procaine amide, Procanbid, SP 100 (pharmaceutical), Sp 100, p-Amino-N-(2-diethylaminoethyl)benzamide, p-Aminobenzoic diethylaminoethylamide
• CAS: 51-06-9

Beschreibung

4-Amino-n-[2-(diethylamino)ethyl]benzamide is a methyltransferase inhibitor that binds to the ryanodine receptor and blocks the release of calcium from sarcoplasmic reticulum. It has been shown to reduce the severity of myocardial infarcts in mice by preventing cell death and reducing inflammation. 4-Amino-n-[2-(diethylamino)ethyl]benzamide has also been used as a therapeutic agent in humans, with promising results. This drug is approved for use in Japan, but not yet in the United States.

4-Amino-n-[2-(diethylamino)ethyl]benzamide is a methyltransferase inhibitor that binds to the ryanodine receptor and blocks the release of calcium from sarcoplasmic reticulum. It has been shown to reduce the severity of myocardial infarcts in

• Marke: Biosynth

Chemische Eigenschaften

• Molekulargewicht: 235.33 g/mol
• Formel: C₁₃H₂₁N₃O
• Reinheit: Min. 95%
• InChl: InChI=1S/C13H21N3O/c1-3-16(4-2)10-9-15-13(17)11-5-7-12(14)8-6-11/h5-8H,3-4,9-10,14H2,1-2H3,(H,15,17)
• InChI Key: InChIKey=REQCZEXYDRLIBE-UHFFFAOYSA-N
• SMILES: CCN(CC)CCNC(=O)c1ccc(N)cc1